Title
Magic Cancer Bullet: How A Tiny Orange Pill May Rewrite Medical History
Processing time: 1-3 days
US Orders Ships in: 3-5 days
International Orders Ships in: 8-12 days
Return Policy: 15-days return on defective items
Payment Option
The Remarkable Story Behind The Revolutionary Miracle Cure For Cancer, Gleevec. Novartis Chairman Dr Dan Vasella Describes Its Development And How He And Novartis Orchestrated The Breakneck Approval And Massive Production Of This Amazing Drug.Pharmaceutical Giant Novartis Recently Developed Gleevec, One Of The First 'Smart' Drugs Created To Kill Cancer Cells Without Damaging Healthy Cells In The Process. In Early Tests With A Common Form Of Leukemia And Other Types Of Cancer, Gleevec Has Been Extraordinarily Successful, And Side Effects Have Been Astoundingly Minimal. Gleevec Communicates Directly With Cancercausing Chromosomes And Interrupts The Signal That Causes Excessive Growth Of Certain White Blood Cells. Patients Have Seen Their Tumours Shrink Significantly, And Some Have Disappeared Altogether.This Is The Inside Story Of The Creation Of This Miracle Drug, And How Novartis Ceo And Chairman Dan Vasella Rallied The Company To Bring Gleevec To Market In Mass Quantities And Record Time.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.
- Q: What is the main topic of 'Magic Cancer Bullet'? A: 'Magic Cancer Bullet' focuses on the development of Gleevec, a revolutionary cancer treatment developed by Novartis, detailing its history and impact on cancer therapy.
- Q: Who is the author of the book? A: The author of 'Magic Cancer Bullet' is Daniel Vasella, who was the chairman of Novartis during the development of Gleevec.
- Q: What makes Gleevec a unique cancer treatment? A: Gleevec is considered a 'smart' drug because it targets cancer cells specifically without harming healthy cells, leading to minimal side effects.
- Q: In which format is the book available? A: 'Magic Cancer Bullet' is available in hardcover format, which is durable and suitable for long-term reading.
- Q: How many pages does the book have? A: 'Magic Cancer Bullet' contains 288 pages, providing an in-depth look at the drug's development and implications.
- Q: When was 'Magic Cancer Bullet' published? A: The book was published on June 3, 2003.
- Q: What condition is the book in? A: 'Magic Cancer Bullet' is listed as a new item, ensuring that it is in pristine condition for readers.
- Q: What is the significance of Gleevec in cancer treatment? A: Gleevec has been significant in cancer treatment as it has shown extraordinary success in early tests against various cancers, particularly leukemia.
- Q: Is there any information about the side effects of Gleevec in the book? A: Yes, the book discusses the minimal side effects observed in patients using Gleevec compared to traditional cancer treatments.
- Q: What category does 'Magic Cancer Bullet' fall under? A: 'Magic Cancer Bullet' is categorized under Company Profiles, focusing on Novartis as a pharmaceutical company.